Extra Virgin Olive Oil Protects the Brain Through the Gut Microbiome: What the New PREDIMED-Plus Study Means for Cognitive Health
- Oleaphen CSO
- Mar 17
- 11 min read
published March 2026
Quick Summary
A January 2026 study published in Microbiome tracked 656 older adults over two years and found that people who consumed virgin olive oil, rather than refined olive oil, showed improved cognitive performance and greater gut microbial diversity.
The researchers identified a specific gut bacterium, Adlercreutzia, that appeared to mediate roughly half of the cognitive benefit. This is the first prospective human study to connect olive oil type, gut microbiota composition, and cognitive function in the same cohort.
The findings add to a growing body of evidence, including Harvard's 92,000-person study linking olive oil to 28% lower dementia mortality, that positions extra virgin olive oil as one of the most accessible dietary interventions for long-term brain health.
The Study: What Happened and Why It Matters
In January 2026, a team led by Jiaqi Ni at the Universitat Rovira i Virgili in Spain published what is, to date, the first prospective human study specifically designed to examine how olive oil affects the brain through the gut microbiome. The research was conducted within the PREDIMED-Plus project, one of the largest and longest-running Mediterranean diet intervention trials in the world.
The team followed 656 adults aged 55 to 75 who were overweight or obese and had metabolic syndrome. Over two years, researchers tracked what type of olive oil participants consumed (virgin versus refined), analyzed the composition of their gut bacteria through stool samples, and measured cognitive performance using standardized tests for memory, language, and problem-solving.
The results were clear on two fronts. Participants who regularly consumed virgin olive oil experienced improvements in cognitive performance. Those consuming refined olive oil did not, and in fact showed decreased gut microbial diversity over the same period.
What separates this study from previous work is the identification of a mechanism. The researchers found that a bacterial genus called Adlercreutzia was significantly more abundant in virgin olive oil consumers, and that changes in Adlercreutzia abundance statistically mediated approximately half of the cognitive improvement observed. Adlercreutzia is known for metabolizing polyphenols and other plant-derived compounds, which provides a biologically plausible pathway connecting olive oil phenolics, gut metabolism, and brain health.
Principal investigator Jordi Salas-Salvado was direct about the implication: the quality of the fat we consume matters as much as the quantity.
"This study doesn't just confirm that olive oil is good for the brain. It identifies a specific microbial mediator, Adlercreutzia, that appears to explain roughly half of the cognitive benefit. That moves us from 'olive oil helps' to 'here is one mechanism by which it helps,' and that's a real advance."
Why Virgin Olive Oil Works and Refined Does Not
The difference between virgin and refined olive oil comes down to processing. Virgin olive oil is extracted mechanically from olives, preserving its full complement of polyphenols, antioxidants, vitamins, and other bioactive compounds. Refined olive oil undergoes industrial treatment designed to remove impurities and extend shelf life. Those treatments also strip out the phenolic compounds responsible for the oil's health benefits.
This is not a marginal difference. Standard refined olive oils contain close to zero polyphenols. A typical extra virgin olive oil contains 50 to 100 mg/kg. High-phenolic extra virgin olive oils can exceed 2,000 mg/kg.
At Oleaphen, our latest harvest was independently verified at 2,236 mg/kg total polyphenols by LC-MS/MS at the Universidad de Cordoba, which is roughly 45 times the concentration found in a standard supermarket EVOO.
The Ni et al. study did not measure the polyphenol content of the oils participants actually consumed. But the divergence in outcomes between virgin and refined olive oil consumers, combined with everything we know about polyphenol bioactivity, strongly suggests that the phenolic fraction is the active ingredient.
The Gut-Brain Axis: How Polyphenols Reach the Brain Through the Gut
One of the most important findings from this study concerns the route by which olive oil polyphenols exert their effects.
Roughly 90 to 95% of ingested polyphenols are not absorbed in the small intestine. They travel intact to the colon, where resident bacteria metabolize them into smaller, bioactive secondary compounds. These metabolites then enter the bloodstream and communicate with the brain through the gut-brain axis, a bidirectional signaling network that uses immunological, neuronal, and metabolic pathways.
The polyphenols in virgin olive oil act as a kind of prebiotic fuel. They selectively promote the growth of beneficial bacteria, including Bifidobacterium, Lactobacillus, and butyrate-producing species. Butyrate is a short-chain fatty acid that strengthens the intestinal barrier and has documented anti-inflammatory effects on the nervous system. A 2025 review published in Food & Function by Rivero-Pino et al. catalogued these effects in detail and concluded that virgin olive oil compounds modulate the gut microbiota in ways directly relevant to brain health.
"Most people think of olive oil polyphenols as antioxidants that go straight to work in the body. The reality is that 90-95% of them reach the colon unabsorbed, where gut bacteria convert them into secondary metabolites that the body can actually use. Your gut bacteria are the pharmacists filling the prescription."
The identification of Adlercreutzia as a mediator is a significant step. This genus belongs to the Coriobacteriaceae family, which has been implicated in cognitive function in other contexts. Coretti et al. (2017) reported that Coriobacteriaceae were depleted in patients with autism spectrum disorder, suggesting this bacterial family may play a broader role in brain function than previously recognized.
The Compounds Behind the Cognitive Benefits
Four olive oil polyphenols carry the strongest mechanistic evidence for brain health.
Oleocanthal has received the most attention in neurodegeneration research. Work by Abuznait and Kaddoumi at the University of Louisiana (2013) demonstrated that oleocanthal enhances clearance of beta-amyloid protein from the brain by upregulating two key transport proteins at the blood-brain barrier: P-glycoprotein and LRP1. A 2015 follow-up study in Alzheimer's model mice (TgSwDI) confirmed that four weeks of oleocanthal treatment significantly reduced amyloid load in the hippocampus and activated the ApoE-dependent clearance pathway. Oleocanthal also inhibits tau fibrillization by binding to lysine residues on the tau protein, locking it in a harmless unfolded state. And it suppresses neuroinflammation through COX-1 and COX-2 inhibition, the same enzymatic pathway targeted by ibuprofen, a connection first identified by Beauchamp et al. in a 2005 study published in Nature.
"Oleocanthal clears amyloid from the brain, prevents tau from tangling, and suppresses the same inflammatory enzymes that ibuprofen targets. No single pharmaceutical on the market hits all three of those Alzheimer's pathways simultaneously."
Hydroxytyrosol is the most extensively studied phenolic alcohol in olive oil and the compound behind the European Food Safety Authority's authorized health claim. It crosses the blood-brain barrier, neutralizes reactive oxygen species, and appears in blood plasma within 30 to 90 minutes of ingestion. Bioavailability studies show that hydroxytyrosol is absorbed at roughly double the rate when consumed within its natural olive oil matrix (44% urinary recovery) compared to water-based preparations (23%).
Oleuropein aglycone has shown direct anti-amyloid activity. Luccarini et al. (2014) demonstrated it counteracts beta-amyloid-42 toxicity in rat brain tissue. A 2024 molecular dynamics study by Paul and Biswas in The Journal of Physical Chemistry B showed that oleuropein aglycone inhibits the self-assembly of tau-derived PHF6 peptides, providing a computational model for how this compound may prevent tangle formation.
Oleacein, the second most abundant secoiridoid in high-quality EVOO, contributes both vascular protective and neuroprotective effects, though it has received less dedicated investigation than oleocanthal.
These compounds do not work in isolation. In their natural olive oil matrix, they are metabolized together by gut bacteria, producing a cascade of secondary metabolites. This is one reason why isolated polyphenol supplements do not replicate the effects observed with whole extra virgin olive oil.
Olive Oil and Brain Health: Where This Study Fits in the Broader Evidence
The Ni et al. findings arrive in the context of rapidly accumulating evidence linking olive oil consumption to brain health.
In May 2024, Tessier et al. published a study in JAMA Network Open analyzing data from over 92,000 American adults tracked for 28 years through the Nurses' Health Study and Health Professionals Follow-Up Study. Participants who consumed at least 7 grams of olive oil per day (roughly half a tablespoon) had a 28% lower risk of dementia-related death compared with those who never or rarely consumed olive oil. That association held after adjusting for overall diet quality and APOE e4 genetic risk.
The PREDIMED-NAVARRA cognitive sub-study (Martinez-Lapiscina et al., 2013) assessed 522 participants after 6.5 years of nutritional intervention and found that a Mediterranean diet supplemented with EVOO improved scores on the Mini-Mental State Examination and Clock Drawing Test compared with a low-fat control diet.
A separate PREDIMED analysis by Valls-Pedret et al. (2015), published in JAMA Internal Medicine, showed that the EVOO group's global cognition composite improved while the control group declined significantly.
In 2022, Kaddoumi et al. published a randomized controlled trial in Nutrients involving 25 patients with mild cognitive impairment. Participants consumed 30 ml of olive oil daily for six months. Only the extra virgin olive oil group (not the refined olive oil group) showed improved blood-brain barrier function and enhanced functional brain connectivity on MRI. This trial was conducted in collaboration with Yale School of Public Health.
A November 2025 review in Frontiers in Nutrition by Wei et al. synthesized the preclinical and clinical evidence, concluding that EVOO polyphenols act on multiple Alzheimer's pathways simultaneously: beta-amyloid deposition, tau hyperphosphorylation, neuroinflammation, and mitochondrial dysfunction.
What the Ni et al. study adds is the gut microbiome as an explicit mediating mechanism in humans. The brain benefits of olive oil polyphenols are not only direct (crossing the blood-brain barrier) but also indirect, routed through the trillions of bacteria in the digestive system.
How Much Olive Oil Do You Need?
Dosage is one of the most practically important questions, and the answer depends heavily on the type of olive oil you use.
The Harvard study by Tessier et al. found benefit at just 7 grams per day (half a tablespoon), but did not differentiate by olive oil type.
The PREDIMED trials used approximately 50 grams per day (about four tablespoons) of extra virgin olive oil. The Kaddoumi RCT used 30 ml daily.
The EFSA health claim requires a minimum of 5 mg of hydroxytyrosol and its derivatives per day.
From a standard supermarket EVOO containing 50 to 100 mg/kg of polyphenols, you would need 50 to 100 ml per day to reach that threshold, adding 450 to 900 calories from oil alone. That is neither practical nor sustainable for most people.
High-phenolic olive oils change this equation. An oil verified at 2,236 mg/kg, like Oleaphen's 2025 harvest, delivers roughly 11 mg of polyphenols in just 5 ml (one teaspoon), at about 45 calories. That is more than double the EFSA minimum in a single small daily dose.
"If you're using a standard grocery-store extra virgin olive oil, you may need 50 to 100 milliliters a day just to reach the minimum effective polyphenol dose. That's up to 900 calories from oil alone. A high-phenolic olive oil at 2,000 mg/kg delivers the same polyphenol load in under 5 milliliters. The concentration of the oil you choose determines whether you're getting a culinary ingredient or a functional dose."
Two additional points matter for practical application. First, consistency over time appears to be more important than occasional large doses. The benefits observed in the Tessier study accumulated over decades of regular intake. Second, the olive oil matrix itself enhances absorption. Polyphenols consumed within olive oil are absorbed at roughly twice the rate of the same compounds delivered in water or supplement form, which means isolated polyphenol capsules are not an equivalent substitute.
Frequently Asked Questions
Is all olive oil good for the brain?
No. The Ni et al. study found that only virgin olive oil consumers saw cognitive improvements. Refined olive oil consumers showed no benefit and actually had decreased gut microbial diversity. The refining process strips out the polyphenols that feed beneficial gut bacteria and cross the blood-brain barrier. The type of olive oil matters at least as much as using olive oil at all.
What is Adlercreutzia and why does it matter?
Adlercreutzia is a genus of gut bacteria within the Coriobacteriaceae family. It specializes in metabolizing plant polyphenols. In the Ni et al. study, higher virgin olive oil consumption was associated with greater abundance of Adlercreutzia, which in turn was linked to better cognitive performance. The genus statistically mediated about half of the observed cognitive benefit, suggesting it plays a key role in converting olive oil polyphenols into neuroactive metabolites.
How does olive oil affect Alzheimer's disease specifically?
Olive oil polyphenols, particularly oleocanthal, target multiple Alzheimer's pathways. Oleocanthal enhances clearance of beta-amyloid from the brain by upregulating transport proteins P-glycoprotein and LRP1 at the blood-brain barrier (Abuznait et al., 2013; Qosa et al., 2015). It inhibits tau protein aggregation. It suppresses neuroinflammation via COX enzyme inhibition. And, as the Ni et al. study shows, olive oil polyphenols also reshape the gut microbiome in ways that support cognitive function through the gut-brain axis.
How much olive oil per day is enough for brain health?
Harvard's 2024 study found lower dementia mortality risk at just 7 grams per day (half a tablespoon). For the polyphenol-specific benefits, the EFSA health claim requires 5 mg of hydroxytyrosol equivalents daily. From a standard EVOO, that means 50 to 100 ml per day. From a high-phenolic oil like Oleaphen (2,236 mg/kg), you reach that dose in under 5 ml. Clinical trials have used 30 ml of EVOO daily for six months with measurable cognitive improvements.
Can I take polyphenol supplements instead of olive oil?
The evidence favors whole olive oil over isolated supplements. Hydroxytyrosol bioavailability is nearly double when consumed within the olive oil matrix (44% urinary recovery) compared to water-based preparations (23%). The oil's fat-soluble environment protects polyphenols during digestion and enhances absorption. Additionally, the multiple compounds in EVOO work synergistically and serve as prebiotic fuel for gut bacteria, effects that isolated supplements do not replicate.
What is the gut-brain axis?
The gut-brain axis is a bidirectional communication system between the intestinal microbiome and the central nervous system. It uses immunological, neuronal (including the vagus nerve), and metabolic pathways. What you feed your gut bacteria influences the signals they send to your brain. The Ni et al. study provides the first prospective human evidence that olive oil type influences cognitive function through this gut-brain communication system.
Scientific References
Ni J, Nishi SK, Babio N, Belzer C, Vioque J, Corella D, et al. Total and different types of olive oil consumption, gut microbiota, and cognitive function changes in older adults. Microbiome. 2026;14(1):68. doi: 10.1186/s40168-025-02306-4
Tessier AJ, Cortese M, Yuan C, Bjornevik K, Ascherio A, Wang DD, et al. Consumption of olive oil and diet quality and risk of dementia-related death. JAMA Network Open. 2024;7(5):e2410021. doi: 10.1001/jamanetworkopen.2024.10021
Kaddoumi A, Denney TS Jr, Deshpande G, Robinson JL, Beyers RJ, Redden DT, et al. Extra-virgin olive oil enhances the blood-brain barrier function in mild cognitive impairment: a randomized controlled trial. Nutrients. 2022;14(23):5102. doi: 10.3390/nu14235102
Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martinez-Gonzalez MA, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Internal Medicine. 2015;175(7):1094-1103. doi: 10.1001/jamainternmed.2015.1668
Martinez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvado J, San Julian B, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. Journal of Neurology, Neurosurgery and Psychiatry. 2013;84(12):1318-1325. doi: 10.1136/jnnp-2012-304792
Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A. Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies. ACS Chemical Neuroscience. 2013;4(6):973-982. doi: 10.1021/cn400024q
Qosa H, Batarseh YS, Mohyeldin MM, El Sayed KA, Keller JN, Kaddoumi A. Oleocanthal enhances amyloid-beta clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model. ACS Chemical Neuroscience. 2015;6(11):1849-1859. doi: 10.1021/acschemneuro.5b00190
Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;437(7055):45-46. doi: 10.1038/437045a
Wei L, Li Z, Shi M, Song W, Teng Z, Zhang C. Neuroprotective properties of extra virgin olive oil polyphenols in Alzheimer's disease: a multi-target mechanistic review. Frontiers in Nutrition. 2025;12:1736633. doi: 10.3389/fnut.2025.1736633
Rivero-Pino F, et al. Unveiling the neuroprotective impact of virgin olive oil ingestion via the microbiota-gut-brain axis. Food & Function. 2025. doi: 10.1039/D4FO04560B
Lauretti E, Iuliano L, Pratico D. Extra-virgin olive oil ameliorates cognition and neuropathology of the 3xTg mice: role of autophagy. Annals of Clinical and Translational Neurology. 2017;4(8):564-574. doi: 10.1002/acn3.431
Luccarini I, Ed Dami T, Grossi C, Rigacci S, Stefani M, Casamenti F. Oleuropein aglycone counteracts Abeta42 toxicity in the rat brain. Neuroscience Letters. 2014;558:67-72. doi: 10.1016/j.neulet.2013.10.062
Paul S, Biswas P. Molecular dynamics simulation study of the self-assembly of tau-derived PHF6 and its inhibition by oleuropein aglycone from extra virgin olive oil. The Journal of Physical Chemistry B. 2024;128(23):5630-5641. doi: 10.1021/acs.jpcb.4c02393
Coretti L, Cristiano C, Florio E, Scala G, Lama A, Keller S, et al. Sex-related alterations of gut microbiota composition in the BTBR mouse model of autism spectrum disorder. Scientific Reports. 2017;7:45356. doi: 10.1038/srep45356
Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine. 2018;378(25):e34. doi: 10.1056/NEJMoa1800389
EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage. EFSA Journal. 2011;9(4):2033. doi: 10.2903/j.efsa.2011.2033
